FERO awards a grant to a CCUN project to improve immunotherapy in lung cancer patients
Dr. Miguel Fernández de Sanmamed, a specialist at the Cancer Center Clínica Universidad de Navarra, has been awarded a grant for young researchers, which will fund a project on intratumoral immunotherapy in patients with operable lung cancer.
November 19, 2025
A project aimed at designing an immunotherapy strategy to reinforce neoadjuvant treatments in lung cancer patients, developed in a laboratory at Cima University of Navarra under the direction of Dr. Miguel Fernández de Sanmamed, has received the FERO Grant for young researchers. This grant, worth €80,000 over the next three years, aims to promote translational research in the fight against cancer.
The award-winning oncologist heads Cima's Applied and Translational Onco-Immunology Group, is a specialist in the Lung Cancer Area at CCUN, and has appeared on the list of the world's most cited scientists for the third consecutive year.
A project aimed at designing an immunotherapy strategy to reinforce neoadjuvant treatments in lung cancer patients, developed in a laboratory at Cima University of Navarra under the direction of Dr. Miguel Fernández de Sanmamed, has received the FERO Grant for young researchers. This grant, worth €80,000 over the next three years, aims to promote translational research in the fight against cancer.
The award-winning oncologist heads Cima's Applied and Translational Onco-Immunology Group, is a specialist in the Lung Cancer Area at CCUN, and has appeared on the list of the world's most cited scientists for the third consecutive year.